“ ConclusionIsothiocyanates enhance response to 4-hydroxytamoxifen , which allows for reduction of the effective drug concentration.”
“ ResultsIsothiocyanates act in a synergistic way with 4-hydroxytamoxifen , and co-treatment reduces breast cancer cell viability and clonogenic potential more effectively than treatment with any single agent.”